AAV-CAG-GFP (Serotype 6.2)

Product Category: Pre-made recombinant AAV | AAV-CAG-GFP | AAV-CBA-GFP | AAV6.2-CAG-GFP | AAV6.2-CBA-GFP
Description:
AAV6.2-CAG-GFP is a pre-packaged recombinant AAV serotype 6.2 vector (AAV6.2 capsid with AAV2 ITRs) that expresses enhanced green fluorescent protein (EGFP) under the control of the CAG promoter (also known as the CBA promoter). The CAG promoter combines the cytomegalovirus (CMV) immediate-early enhancer with the chicken β-actin promoter, enabling robust and ubiquitous transgene expression in a wide range of mammalian cells.
The AAV6.2 capsid contains a single amino acid substitution (F129L) in the VP1 capsid protein compared with wild-type AAV6. This modification provides enhanced transduction efficiency, particularly in primary human airway epithelial cells and murine lung epithelial cells, making AAV6.2 an excellent choice for pulmonary gene delivery and respiratory research.
Supplied in a ready-to-use format for both in vitro and in vivo applications.
Titer: >1E+13 VG/mL
Size: 30 µL (Std Pack)
Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 30 µL at >10¹³ VG/mL, 10 µL at >10¹³ VG/mL |
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.


